We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Peroxisome Proliferator-Activated Receptor Gamma Exacerbates Concanavalin A-Induced Liver Injury via Suppressing the Translocation of NF-κB into the Nucleus.
- Authors
Ogawa, Yuji; Yoneda, Masato; Tomeno, Wataru; Imajo, Kento; Shinohara, Yoshiyasu; Fujita, Koji; Shibata, Wataru; Kirikoshi, Hiroyuki; Saito, Satoru; Wada, Koichiro; Maeda, Shin; Nakajima, Atsushi
- Abstract
Peroxisome proliferator-activated receptor-γ (PPARγ) has been reported to reduce inflammation and attenuate fibrosis in the liver. In this study, we investigated the effects of PPARγ on the liver injury induced by 20 mg/kg Concanavalin A (Con A). The mice were administered one of the three types of PPARγ ligands (pioglitazone, ciglitazone, and troglitazone) for 1 week, and the serum alanine aminotransferase (ALT) levels at 20 h after Con A injection were significantly elevated in the PPARγ ligand-treated mice. Furthermore, the serum ALT levels after Con A injection in the PPARγ hetero-knock-out mice (PPARγ+/- mice) were lower than those in the wild-type mice (WT mice). Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) revealed extensive liver damage induced by Con A in the pioglitazone-treated mice. Electrophoresis mobility shift assay (EMSA) revealed that activation of translocation of nuclear factor- (NF-) κB, which is a suppressor of apoptosis, in the nucleus of the hepatocytes was suppressed in the pioglitazone-treated mice after Con A injection. In this study, we showed that PPARγ exacerbated Con A-induced liver injury via suppressing the translocation of NF-κB into the nucleus, thereby inhibiting the suppression of liver cell apoptosis.
- Subjects
PEROXISOME proliferator-activated receptors; LIVER diseases; APOPTOSIS; PIOGLITAZONE; CONCANAVALIN A; LABORATORY mice
- Publication
PPAR Research, 2012, p1
- ISSN
1687-4757
- Publication type
Article
- DOI
10.1155/2012/940384